- Home
- Publications
- Publication Search
- Publication Details
Title
Challenges and opportunities in NASH drug development
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 29, Issue 3, Pages 562-573
Publisher
Springer Science and Business Media LLC
Online
2023-03-10
DOI
10.1038/s41591-023-02242-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Placebo effect on progression and regression in NASH : Evidence from a meta‐analysis
- (2022) Cheng Han Ng et al. HEPATOLOGY
- Complexity of ballooned hepatocyte feature recognition: Defining a training atlas for artificial intelligence-based imaging in NAFLD
- (2022) Elizabeth M. Brunt et al. JOURNAL OF HEPATOLOGY
- Single Cell RNA Sequencing in Autoimmune Inflammatory Rheumatic Diseases: Current Applications, Challenges and a Step Toward Precision Medicine
- (2022) Tadeja Kuret et al. Frontiers in Medicine
- Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial
- (2022) Naim Alkhouri et al. JOURNAL OF HEPATOLOGY
- Head to head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
- (2022) Beom Kyung Kim et al. JOURNAL OF HEPATOLOGY
- Clinical course of non-alcoholic fatty liver disease and the implications for clinical trial design
- (2022) Alina M. Allen et al. JOURNAL OF HEPATOLOGY
- Clinical Utility of Combined MRI-PDFF and ALT Response in Predicting Histologic Response in Nonalcoholic Fatty Liver Disease
- (2022) Daniel Q. Huang et al. Clinical Gastroenterology and Hepatology
- A perspective on RNA interference-based therapeutics for metabolic liver diseases
- (2021) Naim Alkhouri et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Artificial Intelligence in NASH Histology: Human Teaches a Machine for the Machine to help Humans
- (2021) Mazen Noureddin HEPATOLOGY
- A Machine Learning Approach Enables Quantitative Measurement of Liver Histology and Disease Monitoring in NASH
- (2021) Amaro Taylor‐Weiner et al. HEPATOLOGY
- Automated Analysis of Multiparametric Magnetic Resonance Imaging/Magnetic Resonance Elastography Exams for Prediction of Nonalcoholic Steatohepatitis
- (2021) Bogdan Dzyubak et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Therapeutic pipeline in nonalcoholic steatohepatitis
- (2021) Raj Vuppalanchi et al. Nature Reviews Gastroenterology & Hepatology
- Correlations Between MRI Biomarkers PDFF and cT1 With Histopathological Features of Non-Alcoholic Steatohepatitis
- (2021) Andrea Dennis et al. Frontiers in Endocrinology
- Mechanisms and disease consequences of nonalcoholic fatty liver disease
- (2021) Rohit Loomba et al. CELL
- Application of Artificial Intelligence for Diagnosis and Risk Stratification in NAFLD and NASH‐ the State of the Art
- (2021) Amreen M Dinani et al. HEPATOLOGY
- Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
- (2021) Emmanuel Anandraj Selvaraj et al. JOURNAL OF HEPATOLOGY
- Cirrhosis regression is associated with improved clinical outcomes in patients with nonalcoholic steatohepatitis
- (2021) Arun J. Sanyal et al. HEPATOLOGY
- Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
- (2021) Ramy Younes et al. JOURNAL OF HEPATOLOGY
- MRI-based (MAST) score accurately identifies patients with NASH and significant fibrosis
- (2021) Mazen Noureddin et al. JOURNAL OF HEPATOLOGY
- ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
- (2021) Roberto A. Calle et al. NATURE MEDICINE
- Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease
- (2021) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-Cell Multiomics Analysis for Drug Discovery
- (2021) Sam F. Nassar et al. Metabolites
- Therapeutic landscape for NAFLD in 2020
- (2020) Brent A. Neuschwander-Tetri GASTROENTEROLOGY
- Selonsertib for Patients with Bridging Fibrosis or Compensated Cirrhosis Due to NASH: Results from Randomized Ph III STELLAR Trials
- (2020) Stephen A. Harrison et al. JOURNAL OF HEPATOLOGY
- Complications After Percutaneous Ultrasound‐Guided Liver Biopsy
- (2020) Guo Tian et al. JOURNAL OF ULTRASOUND IN MEDICINE
- Review article: the emerging role of genetics in precision medicine for patients with non-alcoholic steatohepatitis
- (2020) Björn Carlsson et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Standardization of Diet and Exercise in Clinical Trials of NAFLD-NASH: Recommendations from the Liver Forum
- (2020) Oliver Glass et al. JOURNAL OF HEPATOLOGY
- Monitoring Occurrence of Liver-Related Events and Survival by Transient Elastography in Patients With Nonalcoholic Fatty Liver Disease and Compensated Advanced Chronic Liver disease
- (2020) Salvatore Petta et al. Clinical Gastroenterology and Hepatology
- Enhanced Liver Fibrosis Score Can Be Used to Predict Liver-Related Events in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis
- (2020) Vijay S. Are et al. Clinical Gastroenterology and Hepatology
- Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
- (2020) Stephen A. Harrison et al. GASTROENTEROLOGY
- Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials
- (2020) Beth A. Davison et al. JOURNAL OF HEPATOLOGY
- A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study
- (2020) Stephen A Harrison et al. Lancet Gastroenterology & Hepatology
- Change in MRI-PDFF and Histologic Response in Patients with Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis
- (2020) Jonathan G. Stine et al. Clinical Gastroenterology and Hepatology
- Liver Stiffness by Magnetic Resonance Elastography Predicts Future Cirrhosis, Decompensation and Death in NAFLD
- (2020) Tolga Gidener et al. Clinical Gastroenterology and Hepatology
- PNPLA3 rs738409 C>G Variant Predicts Fibrosis Progression by Noninvasive Tools in Nonalcoholic Fatty Liver Disease
- (2020) Grazia Pennisi et al. Clinical Gastroenterology and Hepatology
- Liver biopsy reliability in clinical trials: Thoughts from a liver pathologist
- (2020) Elizabeth Matthews Brunt JOURNAL OF HEPATOLOGY
- Accuracy of cytokeratin 18 (M30 and M65) in detecting non-alcoholic steatohepatitis and fibrosis: A systematic review and meta-analysis
- (2020) Jenny Lee et al. PLoS One
- A composite biomarker using multiparametric magnetic resonance imaging and blood analytes accurately identifies patients with non-alcoholic steatohepatitis and significant fibrosis
- (2020) Andrea Dennis et al. Scientific Reports
- Nonalcoholic Steatohepatitis: Current Thinking from the Division of Hepatology and Nutrition at the Food and Drug Administration
- (2020) Frank A. Anania et al. HEPATOLOGY
- Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
- (2020) Rohit Loomba et al. HEPATOLOGY
- MRI‐Proton Density Fat Fraction Treatment Response Criteria in Nonalcoholic Steatohepatitis
- (2020) Rohit Loomba HEPATOLOGY
- A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis
- (2020) Philip N. Newsome et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Invasive Assessment of Liver Disease in Patients with NAFLD
- (2019) Laurent Castera et al. GASTROENTEROLOGY
- Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2019) Peter J. Eddowes et al. GASTROENTEROLOGY
- Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis
- (2019) Arie Regev et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Past, present and future perspectives in nonalcoholic fatty liver disease
- (2019) Arun J. Sanyal Nature Reviews Gastroenterology & Hepatology
- Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients with Non-alcoholic Fatty Liver Disease
- (2019) Stefania Grimaudo et al. Clinical Gastroenterology and Hepatology
- The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease
- (2019) James M. Paik et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Fibrosis Changes in the Placebo Arm of NASH Clinical Trials
- (2019) Osama Altayar et al. Clinical Gastroenterology and Hepatology
- PNPLA3 I148M and liver fat and fibrosis scores predict liver disease mortality in the United States population
- (2019) Aynur Unalp‐Arida et al. HEPATOLOGY
- Change in hepatic fat content measured by MRI does not predict treatment-induced histological improvement of steatohepatitis
- (2019) Fernando Bril et al. JOURNAL OF HEPATOLOGY
- Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
- (2019) Zobair M Younossi et al. LANCET
- NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances
- (2018) Mazen Noureddin et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Rates and Factors Associated With Placebo Response in Trials of Pharmacotherapies for Nonalcoholic Steatohepatitis: Systematic Review and Meta-analysis
- (2018) Ma Ai Thanda Han et al. Clinical Gastroenterology and Hepatology
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- Lipotoxicity and the gut-liver axis in NASH pathogenesis
- (2018) Fabio Marra et al. JOURNAL OF HEPATOLOGY
- Pharmacotherapy for NASH: Current and emerging
- (2018) Monica A. Konerman et al. JOURNAL OF HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
- (2018) Pegah Golabi et al. MEDICINE
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Genetic Score Associates With Pioglitazone Response in Patients With Non-alcoholic Steatohepatitis
- (2018) Marina Kawaguchi-Suzuki et al. Frontiers in Pharmacology
- Global Perspectives on Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis
- (2018) Zobair Younossi et al. HEPATOLOGY
- Effects of free omega-3 carboxylic acids and fenofibrate on liver fat content in patients with hypertriglyceridemia and non-alcoholic fatty liver disease: A double-blind, randomized, placebo-controlled study
- (2018) Jan Oscarsson et al. Journal of Clinical Lipidology
- Factors Associated With Histologic Response in Adult Patients With Nonalcoholic Steatohepatitis
- (2018) Rohit Loomba et al. GASTROENTEROLOGY
- The role of 3D-MRE in the diagnosis of NASH in obese patients undergoing bariatric surgery
- (2018) Alina M. Allen et al. HEPATOLOGY
- HSD17B13 is a Hepatic Retinol Dehydrogenase Associated with Histological Features of Non-Alcoholic Fatty Liver Disease
- (2018) Yanling Ma et al. HEPATOLOGY
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis
- (2017) Parambir S. Dulai et al. HEPATOLOGY
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus
- (2016) Kenneth Cusi et al. ANNALS OF INTERNAL MEDICINE
- Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
- (2016) Vlad Ratziu et al. GASTROENTEROLOGY
- The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent
- (2016) Rosellina Margherita Mancina et al. GASTROENTEROLOGY
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- Diagnostic accuracy and prognostic significance of blood fibrosis tests and liver stiffness measurement by FibroScan in non-alcoholic fatty liver disease
- (2016) Jérôme Boursier et al. JOURNAL OF HEPATOLOGY
- Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
- (2016) Michael Pavlides et al. JOURNAL OF HEPATOLOGY
- Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment
- (2016) Meric Erikci Ertunc et al. JOURNAL OF LIPID RESEARCH
- Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
- (2016) Petra Hirsova et al. JOURNAL OF LIPID RESEARCH
- Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
- (2016) Matthew James Armstrong et al. LANCET
- The Primary Outcome Is Positive — Is That Good Enough?
- (2016) Stuart J. Pocock et al. NEW ENGLAND JOURNAL OF MEDICINE
- PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery
- (2016) Marcin Krawczyk et al. Surgery for Obesity and Related Diseases
- Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
- (2015) Paul Angulo et al. GASTROENTEROLOGY
- Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up
- (2015) Mattias Ekstedt et al. HEPATOLOGY
- DNA-PK--A Candidate Driver of Hepatocarcinogenesis and Tissue Biomarker That Predicts Response to Treatment and Survival
- (2014) L. Cornell et al. CLINICAL CANCER RESEARCH
- Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study
- (2014) Rohit Loomba et al. HEPATOLOGY
- Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
- (2014) Julia Kozlitina et al. NATURE GENETICS
- Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
- (2014) Yoshio Sumida WORLD JOURNAL OF GASTROENTEROLOGY
- Serum Cytokeratin-18 Fragment Levels Are Useful Biomarkers for Nonalcoholic Steatohepatitis in Children
- (2013) Ariel E Feldstein et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials
- (2013) Mazen Noureddin et al. HEPATOLOGY
- Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene
- (2013) Hwa-Li Tan et al. JOURNAL OF GASTROENTEROLOGY
- The Role of Endoplasmic Reticulum in Hepatic Lipid Homeostasis and Stress Signaling
- (2012) Suneng Fu et al. Cell Metabolism
- The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology
- (2012) Naga Chalasani et al. GASTROENTEROLOGY
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- In patients with non-alcoholic fatty liver disease, metabolically abnormal individuals are at a higher risk for mortality while metabolically normal individuals are not
- (2012) Zobair M. Younossi et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Drug safety assessment in clinical trials: methodological challenges and opportunities
- (2012) Sonal Singh et al. Trials
- Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH)
- (2011) Paul B. Watkins et al. DRUG SAFETY
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- (2011) Arun J. Sanyal et al. HEPATOLOGY
- Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality
- (2011) Zobair M. Younossi et al. HEPATOLOGY
- Effects of interventions on intra- and interobserver agreement on interpretation of nonalcoholic fatty liver disease histology
- (2010) Samer Gawrieh et al. Annals of Diagnostic Pathology
- Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study
- (2010) Adrian Reuben et al. HEPATOLOGY
- The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
- (2010) Mustafa S. Ascha et al. HEPATOLOGY
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study
- (2009) Ariel E. Feldstein et al. HEPATOLOGY
- Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent
- (2009) S Romeo et al. INTERNATIONAL JOURNAL OF OBESITY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started